These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30026451)

  • 1. [A Case of Consciousness Disorder Induced by the Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Cisplatin and 5-Fluorouracil Chemotherapy in a Patient with Tongue Cancer].
    Tamura T; Taniguchi N; Otsuki K; Narai T; Kawasaki M; Fujii N; Doi R; Kodani I
    Gan To Kagaku Ryoho; 2018 May; 45(5):855-857. PubMed ID: 30026451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of consciousness disorder induced by the syndrome of inappropriate secretion of antidiuretic hormone following cisplatin and 5-fluorouracil chemotherapy in a patient with esophageal cancer].
    Endo C; Takagawa R; Chiba T; Kawamoto M; Konishi T; Honma Y; Minami Y; Watanabe J; Morita T; Mogaki M; Masui H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2130-2. PubMed ID: 24394036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of syndrome of inappropriate antidiuretic hormone secretion in a patient with esophageal carcinoma possibly induced by cisplatin in neoadjuvant chemotherapy].
    Sawano T; Kawasaki H; Wajima N; Miyamoto K; Ishizawa Y; Nakai M; Hakamada K
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):999-1003. PubMed ID: 25132033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Syndrome of inappropriate antidiuretic hormone secretion following adjuvant CDDP and 5-FU administration in a patient with esophageal carcinoma].
    Horio T; Tsujimoto H; Akase T; Sakamoto N; Yaguchi Y; Hiraki S; Aiko S; Takechi H; Hase K; Maehara T
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):1945-8. PubMed ID: 20948261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung].
    Fukabori T; Nakamura T; Kida T; Fujita Y; Goto T; Hiramori N; Fujii T; Iwasaki Y; Nakagawa M
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1213-6. PubMed ID: 2053780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of SIADH developed during neoadjuvant chemotherapy using nedaplatin and 5-fluorouracil in a patient with esophageal cancer].
    Matsuda Y; Lee S; Kishida S; Mori K; Isohata N; Iwasaki H; Hashiba R; Gyobu K; Osugi H
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1787-90. PubMed ID: 20841948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer.
    Furusaka T; Asakawa T; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2012 Oct; 132(10):1108-14. PubMed ID: 22998559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy.
    Futai R; Yoshie T; Sanuki T; Inoue Y; Abe T; Sasaki A; Iemoto T; Hayashi H; Ose T; Morikawa T
    Am J Case Rep; 2022 Feb; 23():e935121. PubMed ID: 35167511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M; Kanke M; Tomita T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer--for tongue cancer patients in comparison patients with other therapies].
    Furusaka T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1241-6. PubMed ID: 16969018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Syndrome of inappropriate secretion of ADH following chemoradiation therapy].
    Kikuchi N; Masuda M; Tamura T; Nakazawa K; Kanemoto K; Iijima H; Ishikawa H; Sato S; Ishii Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1711-4. PubMed ID: 23152025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndrome of inappropriate secretion of antidiuretic hormone induced by intraarterial cisplatin chemotherapy.
    Ishii K; Aoki Y; Sasaki M; Tanaka K
    Gynecol Oncol; 2002 Oct; 87(1):150-1. PubMed ID: 12468358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyponatremia with cisplatin administration in head and neck cancer patients].
    Yajima Y; Fujii M; Tokumaru Y; Habu N
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2861-5. PubMed ID: 21160261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of reversible encephalopathy syndrome caused by hyponatremia during neoadjuvant 5-FU+CDDP therapy for esophageal cancer].
    Kobayashi Y; Nozaki I; Hato S; Kobatake T; Ohta K; Kubo Y; Tanada M; Kurita A
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):379-81. PubMed ID: 23507603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndrome of inappropriate secretion of antidiuretic hormone following intra-thoracic cisplatin.
    Otsuka F; Hayashi Y; Ogura T; Hayakawa N; Ikeda S; Makino H; Ota Z
    Intern Med; 1996 Apr; 35(4):290-4. PubMed ID: 8739784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
    Jimeno A; Machiels JP; Wirth L; Specenier P; Seiwert TY; Mardjuadi F; Wang X; Kapp AV; Royer-Joo S; Penuel E; McCall B; Pirzkall A; Clement PM
    Cancer; 2016 Dec; 122(24):3803-3811. PubMed ID: 27525588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypopharyngeal cancer.
    Kusuki M; Iguchi H; Nakamura A; Nishiura H; Kanazawa A; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):74-7. PubMed ID: 15513517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.